Skip to main content

Closed

AZN: AstraZeneca PLC Stock Analysis | finqOS

Healthcare · Drug Manufacturers - General

Loading chart data...

Current StateBalance holding

The verdict

Good business

Strong

Revenue growth+18.0% / yr

Operating margin22.7%

ROIC12.7%

Financially safe

Strong

Debt / equity0.64×

Interest coverage8.0×

Current ratio0.89×

Valuation

Unrated

P/E ratio25.3×

Dividend yield1.9%

AstraZeneca PLC

AZNNew York Stock Exchange·USD·Closed

AstraZeneca PLC

AZNNew York Stock Exchange·USD·Closed

$169.64

−0.99%

$169.64

−$1.70 (0.99%)

52W Range

36thpctl

Volume

0.70×avg

Mkt Cap

131.47BUSD

P/E

25.3TTM

Div Yield

1.87%ann

52W Range

36thpctl

Volume

0.70×avg

Market Cap

131.47BUSD

P/E Ratio

25.3TTM

Div Yield

1.87%ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings